Work management software maker Asana (NYSE: ASAN) will be reporting results tomorrow afternoon. Here's what to expect.
Last quarter Asana reported revenues of $162.5 million, up 20.4% year on year, beating analyst revenue expectations by 3%. It was a mixed quarter for the company, with a decent beat of analysts' revenue estimates. On the other hand, billings (another important topline metric) missed, and net revenue retention fell from last quarter's levels and was below expectations.The company added 918 enterprise customers paying more than $5,000 annually to a total of 20,782.
Is Asana buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting Asana's revenue to grow 16% year on year to $164.1 million, slowing down from the 41% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.11 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company has a history of exceeding Wall St's expectations, beating revenue estimates every single time over the past two years on average by 4.2%.
Looking at Asana's peers in the productivity software segment, some of them have already reported Q3 earnings results, giving us a hint of what we can expect. Atlassian (NASDAQ:TEAM) delivered top-line growth of 21.1% year on year, beating analyst estimates by 1.3% and Monday.com reported revenues up 38.2% year on year, exceeding estimates by 3.7%. Atlassian traded down 11.8% on the results, Monday.com was up 9.7%.
Read the full analysis of Atlassian's and Monday.com's results on StockStory.
There has been positive sentiment among investors in the productivity software segment, with the stocks up on average 14.3% over the last month. Asana is up 18.9% during the same time, and is heading into the earnings with analyst price target of $20.9, compared to share price of $22.5.
The author has no position in any of the stocks mentioned.